...
首页> 外文期刊>Journal of Clinical Microbiology >Phase Variation of NadA in Invasive Neisseria meningitidis Isolates Impacts on Coverage Estimates for 4C-MenB, a MenB Vaccine
【24h】

Phase Variation of NadA in Invasive Neisseria meningitidis Isolates Impacts on Coverage Estimates for 4C-MenB, a MenB Vaccine

机译:NadA在侵袭性脑膜炎奈瑟氏球菌中的相变可分离对MenB疫苗4C-MenB覆盖率估计值的影响。

获取原文
   

获取外文期刊封面封底 >>

       

摘要

A recombinant NadA protein is one of the four major protective antigens of 4C-MenB (Bexsero), a vaccine developed for serogroup B Neisseria meningitidis (MenB). The meningococcal antigen typing system (MATS) is utilized as a high-throughput assay for assessing the invasive MenB strain coverage of 4C-MenB. ABSTRACT A recombinant NadA protein is one of the four major protective antigens of 4C-MenB (Bexsero), a vaccine developed for serogroup B Neisseria meningitidis (MenB). The meningococcal antigen typing system (MATS) is utilized as a high-throughput assay for assessing the invasive MenB strain coverage of 4C-MenB. Where present, the nadA gene is subject to phase-variable changes in transcription due to a 5′TAAA repeat tract located in a regulatory region. The promoter-containing intergenic region (IGR) sequences and 5′TAAA repeat numbers were determined for 906 invasive meningococcal disease isolates possessing the nadA gene. Exclusion of the 5′TAAA repeats reduced the number of IGR alleles from 82 to 23. Repeat numbers were associated with low and high levels of NadA expression by Western blotting and enzyme-linked immunosorbent assay (ELISA). Low-expression repeat numbers were present in 83% of 179 MenB isolates with NadA-2/3 or NadA-1 peptide variants and 68% of 480 MenW ST-11 complex isolates with NadA-2/3 peptide variants. For isolates with vaccine-compatible NadA variants, 93% of MATS-negative isolates were associated with low-expression repeat numbers, whereas 63% of isolates with MATS relative potency (RP) scores above the 95% confidence interval for the positive bactericidal threshold had high-expression repeat numbers. Analysis of 5′TAAA repeat numbers has potential as a rapid, high-throughput method for assessing strain coverage for the NadA component of 4C-MenB. A key application will be assessing coverage in meningococcal disease cases where confirmation is by PCR only and MATS cannot be applied.
机译:重组NadA蛋白是4C-MenB(Bexsero)的四种主要保护性抗原之一,这是针对B型脑膜炎奈瑟氏球菌(MenB)研制的疫苗。脑膜炎球菌抗原分型系统(MATS)被用作高通量检测方法,用于评估4C-MenB的侵袭性MenB菌株覆盖率。摘要重组NadA蛋白是4C-MenB(Bexsero)的四种主要保护性抗原之一,这是针对B型脑膜炎奈瑟氏球菌(MenB)研制的疫苗。脑膜炎球菌抗原分型系统(MATS)被用作高通量检测方法,用于评估4C-MenB的侵入性MenB菌株覆盖率。如果存在,由于5'TAAA重复序列位于调控区域,因此nadA基因的转录会发生相变变化。确定了906个具有nadA基因的侵袭性脑膜炎球菌分离株的含启动子的基因间区域(IGR)序列和5'TAAA重复数。排除5'TAAA重复序列,将IGR等位基因的数目从82减少到23。通过Western印迹和酶联免疫吸附测定(ELISA),重复数目与NadA表达的低和高水平相关。在179个具有NadA-2 / 3或NadA-1肽变体的MenB分离株中的83%和480个具有NadA-2 / 3肽变体的MenW ST-11复合体分离株中的68%,存在低表达重复数。对于具有疫苗相容性NadA变体的分离株,有93%的MATS阴性分离株与低表达重复数相关,而63%的MATS相对效力(RP)得分高于阳性杀菌阈值95%置信区间的分离株高表达重复数。 5'TAAA重复数的分析作为评估4C-MenB NadA组分的菌株覆盖率的快速,高通量方法具有潜力。一个关键的应用将是评估脑膜炎球菌病病例的覆盖率,这些病例只能通过PCR进行确认,而无法应用MATS。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号